Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Clinical trial NCT05663866 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05663866
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-18
- Primary completion
- 2024-03-29
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.